InsidersTradesSigma
Follow the 카나프테라퓨틱스 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 카나프테라퓨틱스 has recorded 3 public disclosures. Market capitalisation: €162bn. The latest transaction was disclosed on 23 March 2026 (Purchase). Among the most active insiders: 김동건. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Kanap Therapeutics 是一家在医疗保健和制药领域运营的公司，在 XKRX 市场上市。它专注于开发创新的治疗方法和解决方案。